InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-2.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by King Rachel K., 董事. Officer active across 2 companies, notably NOVAVAX INC. In total, 11 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €116k. History available since 19 May 2021. The latest transaction was disclosed on 12 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to King Rachel K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
10,420 股0Common StockSEC:0001593968-25-000760:0
4,150 股@ US$9.020518.2% 占其流量Common StockSEC:0001593968-25-000011:0
6,670 股0Common StockSEC:0001593968-24-000862:0
3,334 股@ US$3.0033.4% 占其流量Common StockSEC:0001415889-24-009743:0
4,238 股@ US$2.3632.5% 占其流量Common stockSEC:0001209191-24-000068:0
6,667 股@ US$1.5034.1% 占其流量Common stockSEC:0001209191-23-051390:0
3,100 股Common StockSEC:0001209191-23-036748:0
700 股Common StockSEC:0001209191-22-038593:0
3,450 股Common StockSEC:0001209191-21-052810:0
6,900 股Common StockSEC:0001209191-21-043702:0
700 股@ US$139.6469.2% 占其流量Common StockSEC:0001209191-21-035008:0
标准退出：2021年8月17日 (T+90)
11 条申报中的 11 条
About King Rachel K.
Rachel K. King is a Board Member at Novavax Inc. She plays a key role in the governance of the company, contributing to the definition of its strategy and guiding its research efforts. Her experience in the biopharmaceutical sector is valuable in guiding Novavax in its vaccine development initiatives.
